Lucid Diagnostics Inc. (LUCD) Reports In-Line Q1 EPS

Lucid Diagnostics Inc. (NASDAQ: LUCD) reported Q1 EPS of ($0.07), in-line with the analyst estimate of ($0.07). Revenue for the quarter came in at $1.26 million versus the consensus estimate of $1.38 million.

For earnings history and earnings-related data on Lucid Diagnostics Inc. (LUCD) click here.

You May Also Be Interested In

• Carnival Corp. (CCL) Tops Q2 EPS by 8c, Beats on Revenue; Offers Guidance
• Trump administration to offer $17.5 billion for nuclear reactors
• Meta unveils lower-priced AI smart glasses starting at $299